Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kewaunee Scientific (KEQU) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Kewaunee Scientific (KEQU) over the last 16 years, with Q4 2025 value amounting to -$853000.0.

  • Kewaunee Scientific's Cash from Financing Activities rose 7358.32% to -$853000.0 in Q4 2025 from the same period last year, while for Oct 2025 it was $8.0 million, marking a year-over-year increase of 19991.24%. This contributed to the annual value of $7.4 million for FY2025, which is 34588.59% up from last year.
  • Kewaunee Scientific's Cash from Financing Activities amounted to -$853000.0 in Q4 2025, which was up 7358.32% from -$1.5 million recorded in Q3 2025.
  • In the past 5 years, Kewaunee Scientific's Cash from Financing Activities ranged from a high of $14.6 million in Q1 2025 and a low of -$4.7 million during Q1 2022
  • Over the past 5 years, Kewaunee Scientific's median Cash from Financing Activities value was $99000.0 (recorded in 2022), while the average stood at $1.4 million.
  • Per our database at Business Quant, Kewaunee Scientific's Cash from Financing Activities surged by 63931.03% in 2023 and then crashed by 52653.06% in 2025.
  • Kewaunee Scientific's Cash from Financing Activities (Quarter) stood at $4.8 million in 2021, then crashed by 103.0% to -$145000.0 in 2022, then surged by 639.31% to $782000.0 in 2023, then tumbled by 512.92% to -$3.2 million in 2024, then skyrocketed by 73.58% to -$853000.0 in 2025.
  • Its Cash from Financing Activities was -$853000.0 in Q4 2025, compared to -$1.5 million in Q3 2025 and -$4.3 million in Q2 2025.